Medical considerations affecting risk–benefit calculus and the decision to authorize medical cannabis
| Medical profile characteristic | No. (%) of interviews | No. (%) of coded references |
|---|---|---|
| No. of therapeutic attempts | 16 (89) | 46 (2.4) |
| Prognosis | 16 (89) | 46 (2.4) |
| Symptom severity | 13 (72) | 25 (1.3) |
| Duration of use | 3 (17) | 3 (0.2) |